DUONEB Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Duoneb, and what generic alternatives are available?
Duoneb is a drug marketed by Mylan Speciality Lp and is included in one NDA.
The generic ingredient in DUONEB is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Duoneb
A generic version of DUONEB was approved as albuterol sulfate; ipratropium bromide by CIPLA on December 31st, 2007.
Summary for DUONEB
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 3 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DUONEB at DailyMed |
Recent Clinical Trials for DUONEB
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Hospitals Cleveland Medical Center | Phase 1 |
Shin-hwar Wu | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for DUONEB
US Patents and Regulatory Information for DUONEB
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | DUONEB | albuterol sulfate; ipratropium bromide | SOLUTION;INHALATION | 020950-001 | Mar 21, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DUONEB
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan Speciality Lp | DUONEB | albuterol sulfate; ipratropium bromide | SOLUTION;INHALATION | 020950-001 | Mar 21, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DUONEB
See the table below for patents covering DUONEB around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | PA04003927 | UNA SOLUCION DE INHALACION DE ALBUTEROL E IPRATROPIO, SISTEMA, EQUIPO Y METODO PARA ALIVIAR SINTOMAS DE ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA. (AN ALBUTEROL AND IPRATROPIUM INHALATION SOLUTION, SYSTEM, KIT AND METHOD FOR RELIEVING SYMPTOMS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE.) | ⤷ Try a Trial |
Japan | 2006505486 | ⤷ Try a Trial | |
Australia | 2006202585 | ⤷ Try a Trial | |
New Zealand | 552548 | An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease | ⤷ Try a Trial |
European Patent Office | 1446045 | ⤷ Try a Trial | |
China | 1607940 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |